Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Abstract

The WHO classification is feasible and provides valuable prognostic information, even in a short-term prospective study. Together with cytogenetic data and other prognostic parameters, the WHO classification is very useful for clinical decision making.